Urpo Lamminmäki

2.1k total citations
99 papers, 1.5k citations indexed

About

Urpo Lamminmäki is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Ecology. According to data from OpenAlex, Urpo Lamminmäki has authored 99 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 53 papers in Radiology, Nuclear Medicine and Imaging and 17 papers in Ecology. Recurrent topics in Urpo Lamminmäki's work include Monoclonal and Polyclonal Antibodies Research (52 papers), Glycosylation and Glycoproteins Research (24 papers) and Bacteriophages and microbial interactions (16 papers). Urpo Lamminmäki is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (52 papers), Glycosylation and Glycoproteins Research (24 papers) and Bacteriophages and microbial interactions (16 papers). Urpo Lamminmäki collaborates with scholars based in Finland, United States and Sweden. Urpo Lamminmäki's co-authors include Markus Vehniäinen, Janne Leivo, Tero Soukka, Kim Pettersson, Kamlesh Gidwani, Tuomas Huovinen, Petri Saviranta, Ville Santala, Teemu Korpimäki and Timo Lövgren and has published in prestigious journals such as Nature, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Urpo Lamminmäki

96 papers receiving 1.5k citations

Peers

Countries citing papers authored by Urpo Lamminmäki

Since Specialization

Citations

This map shows the geographic impact of Urpo Lamminmäki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Urpo Lamminmäki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Urpo Lamminmäki more than expected).

Fields of papers citing papers by Urpo Lamminmäki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Urpo Lamminmäki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Urpo Lamminmäki. The network helps show where Urpo Lamminmäki may publish in the future.

Co-authorship network of co-authors of Urpo Lamminmäki

This figure shows the co-authorship network connecting the top 25 collaborators of Urpo Lamminmäki. A scholar is included among the top collaborators of Urpo Lamminmäki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Urpo Lamminmäki. Urpo Lamminmäki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Plasma CHI3L1 associates with brain volume loss and glial activation in multiple sclerosis 2025 ·Journal of Neurology Neurosurgery & Psychiatry ·(unknown), Maija Saraste, Marjo Nylund, Markus Matilainen, (unknown), (unknown), (unknown), Sauli Laaksonen, (unknown), Jens Kühle, David Leppert, Tero Soukka, Urpo Lamminmäki, Laura Airas	1
2	Developing and validating anti-ADA2 single-chain antibodies coupled to alkaline phosphatase for diagnosing pleural tuberculosis 2025 ·Frontiers in Immunology ·(unknown), José M. Porcel, Urpo Lamminmäki, Silvia Bielsa, Andrey V. Zavialov	0
3	Isolation and functional analysis of phage‐displayed antibody fragments targeting the staphylococcal superantigen‐like proteins 2023 ·MicrobiologyOpen ·(unknown), (unknown), (unknown), Carla J. C. de Haas, Jos A. G. van Strijp, Urpo Lamminmäki, Outi M. H. Salo‐Ahen	2
4	Selection of biophysically favorable antibody variants using a modified Flp-In CHO mammalian display platform 2023 ·Frontiers in Bioengineering and Biotechnology ·(unknown), Rune Salbo, Urpo Lamminmäki, Stuart Prince	6
5	Genotyped functional screening of soluble Fab clones enables in-depth analysis of mutation effects 2023 ·Scientific Reports ·(unknown), (unknown), (unknown), Urpo Lamminmäki, Tuomas Huovinen	2
6	Archaic chaperone–usher pili self-secrete into superelastic zigzag springs 2022 ·Nature ·Natalia Pakharukova, (unknown), Minna Tuittila, Tobias Dahlberg, Debnath Ghosal, Yi‐Wei Chang, (unknown), Sari Paavilainen, Stefan D. Knight, Urpo Lamminmäki, Bernt Eric Uhlin, Magnus Andersson, Grant J. Jensen, Anton V. Zavialov	22
7	Integrins are enriched on aberrantly fucosylated tumour‐derived urinary extracellular vesicles 2022 ·SHILAP Revista de lepidopterología ·Md. Khirul Islam, Bert Dhondt, (unknown), (unknown), Kamlesh Gidwani, Jason Webber, An Hendrix, Guido Jenster, Tarja Lamminen, Peter J. Boström, Kim Pettersson, Urpo Lamminmäki, Janne Leivo	6
8	Single-step noncompetitive immunocomplex immunoassay for rapid aflatoxin detection 2022 ·Food Chemistry ·Riikka Peltomaa, (unknown), Tapani Yli‐Mattila, Urpo Lamminmäki	19
9	A 15-min non-competitive homogeneous assay for microcystin and nodularin based on time-resolved Förster resonance energy transfer (TR-FRET) 2021 ·Analytical and Bioanalytical Chemistry ·(unknown), Urpo Lamminmäki	6
10	Detection of bladder cancer with aberrantly fucosylated ITGA3 2021 ·Analytical Biochemistry ·Md. Khirul Islam, (unknown), Bert Dhondt, Kamlesh Gidwani, Kim Pettersson, Urpo Lamminmäki, Janne Leivo	14
11	Site-Specific Linking of an Oligonucleotide to Mono- and Bivalent Recombinant Antibodies with SpyCatcher-SpyTag System for Immuno-PCR 2020 ·ACS Omega ·(unknown), (unknown), Tuomas Huovinen, Pasi Virta, Urpo Lamminmäki	6
12	Molecular tools for selective recovery and detection of lignin-derived molecules 2018 ·Green Chemistry ·(unknown), (unknown), Elena Efimova, Alexander Efimov, Vesa P. Hytönen, Urpo Lamminmäki, Suvi Santala, Ville Santala	6
13	Next generation sequencing of all variable loops of synthetic single framework scFv—Application in anti-HDL antibody selections 2016 ·New Biotechnology ·Janita Lövgren, Juha‐Pekka Pursiheimo, (unknown), Jussi Salmi, Urpo Lamminmäki	12
14	Identification and analysis of anti-HDL scFv-antibodies obtained from phage display based synthetic antibody library 2016 ·WOS ·(unknown), Janita Lövgren, (unknown), (unknown), Jari Metso, Tuomas Huovinen, (unknown), Kim Pettersson, Matti Jauhiainen, Urpo Lamminmäki	1
15	Development of recombinant antibody-based enzyme-linked immunosorbent assay (ELISA) for the detection of skatole 2015 ·Analytical Biochemistry ·Janne Leivo, (unknown), Jaana Rosenberg, Urpo Lamminmäki	6
16	Two ScFv antibody libraries derived from identical VL-VH framework with different binding site designs display distinct binding profiles 2013 ·Protein Engineering Design and Selection ·Tuomas Huovinen, (unknown), (unknown), (unknown), Alex Azhayev, Qun Wang, Markus Vehniäinen, Urpo Lamminmäki	39
17	High-performance closed-tube PCR based on switchable luminescence probes 2012 ·Analytica Chimica Acta ·(unknown), Ulla Karhunen, (unknown), Urpo Lamminmäki, Tero Soukka	18
18	Synthetic single-framework antibody library integrated with rapid affinity maturation by VL shuffling 2011 ·Protein Engineering Design and Selection ·(unknown), (unknown), (unknown), Tuomas Huovinen, (unknown), Janne Leivo, (unknown), Alex Azhayev, Timo Lövgren, J. Hellman, Urpo Lamminmäki	36
19	Development of a denaturation/renaturation‐based production process for ferritin nanoparticles 2008 ·Biotechnology and Bioengineering ·Anu Jääskeläinen, Tero Soukka, Urpo Lamminmäki, Teemu Korpimäki, Marko Virta	9
20	Crystal Structure of a Recombinant Anti-estradiol Fab Fragment in Complex with 17β-Estradiol 2001 ·Journal of Biological Chemistry ·Urpo Lamminmäki, Jussi Kankare	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact